药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Metildigoxin
Metildigoxin may decrease the cardiotoxic activities of Arsenic trioxide.
Tazarotene
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Arsenic trioxide.
Tazarotene
Cymarin
Cymarin may decrease the cardiotoxic activities of Arsenic trioxide.
Tazarotene
Oleandrin
Oleandrin may decrease the cardiotoxic activities of Arsenic trioxide.
Tazarotene
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Arsenic trioxide.
Tazarotene
Nicorandil
Nicorandil may increase the hypotensive activities of Arsenic trioxide.
Tazarotene
Fingolimod
Arsenic trioxide may increase the immunosuppressive activities of Fingolimod.
Tazarotene
Tofacitinib
Arsenic trioxide may increase the immunosuppressive activities of Tofacitinib.
Tazarotene
Levodopa
The risk or severity of hypotension and orthostatic hypotension can be increased when Arsenic trioxide is combined with Levodopa.
Tazarotene
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Arsenic trioxide.
Tazarotene
Peginesatide
The risk or severity of Thrombosis can be increased when Arsenic trioxide is combined with Peginesatide.
Tazarotene
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Roflumilast
Roflumilast may increase the immunosuppressive activities of Arsenic trioxide.
Tazarotene
Difluocortolone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Difluocortolone.
Tazarotene
Clobetasol
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Clobetasol.
Tazarotene
Fluocortolone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluocortolone.
Tazarotene
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydrocortisone butyrate.
Tazarotene
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Arsenic trioxide.
Tazarotene
Clobetasol propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Arsenic trioxide.
Tazarotene
Siponimod
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Siponimod.